1
|
Jere SW, Abrahamse H, Houreld NN. Interaction of the AKT and β-catenin signalling pathways and the influence of photobiomodulation on cellular signalling proteins in diabetic wound healing. J Biomed Sci 2023; 30:81. [PMID: 37735655 PMCID: PMC10515080 DOI: 10.1186/s12929-023-00974-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2023] [Accepted: 09/14/2023] [Indexed: 09/23/2023] Open
Abstract
The induction of a cells destiny is a tightly controlled process that is regulated through communication between the matrix and cell signalling proteins. Cell signalling activates distinctive subsections of target genes, and different signalling pathways may be used repeatedly in different settings. A range of different signalling pathways are activated during the wound healing process, and dysregulated cellular signalling may lead to reduced cell function and the development of chronic wounds. Diabetic wounds are chronic and are characterised by the inability of skin cells to act in response to reparative inducements. Serine/threonine kinase, protein kinase B or AKT (PKB/AKT), is a central connection in cell signalling induced by growth factors, cytokines and other cellular inducements, and is one of the critical pathways that regulate cellular proliferation, survival, and quiescence. AKT interacts with a variety of other pathway proteins including glycogen synthase kinase 3 beta (GSK3β) and β-catenin. Novel methodologies based on comprehensive knowledge of activated signalling pathways and their interaction during normal or chronic wound healing can facilitate quicker and efficient diabetic wound healing. In this review, we focus on interaction of the AKT and β-catenin signalling pathways and the influence of photobiomodulation on cellular signalling proteins in diabetic wound healing.
Collapse
Affiliation(s)
- Sandy Winfield Jere
- Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, P.O. Box 17011, Doornfontein, 2028 South Africa
| | - Heidi Abrahamse
- Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, P.O. Box 17011, Doornfontein, 2028 South Africa
| | - Nicolette Nadene Houreld
- Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, P.O. Box 17011, Doornfontein, 2028 South Africa
| |
Collapse
|
2
|
Li Z, Crago M, Schofield T, Zeng H, Vyas HKN, Müllner M, Mai-Prochnow A, Farajikhah S, Naficy S, Dehghani F, Talebian S. Synthesis and Evaluation of Functionalized Polyurethanes for pH-Responsive Delivery of Compounds in Chronic Wounds. Gels 2023; 9:611. [PMID: 37623066 PMCID: PMC10454082 DOI: 10.3390/gels9080611] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2023] [Revised: 07/25/2023] [Accepted: 07/27/2023] [Indexed: 08/26/2023] Open
Abstract
Chronic wounds, depending on the bacteria that caused the infection, can be associated with an extreme acidic or basic pH. Therefore, the application of pH-responsive hydrogels has been instigated for the delivery of therapeutics to chronic wounds. Herein, with the aim of developing a flexible pH-responsive hydrogel, we functionalized hydrophilic polyurethanes with either cationic (polyethylene imine) or anionic (succinic anhydride) moieties. A comprehensive physicochemical characterization of corresponding polymers was carried out. Particularly, when tested in aqueous buffers, the surface charge of hydrogel films was closely correlated with the pH of the buffers. The loading of the cationic and anionic hydrogel films with various compound models (bromophenol blue; negatively charged or Pyronin Y; positively charged) showed that the electrostatic forces between the polymeric backbone and the compound model will determine the ultimate release rate at any given pH. The potential application of these films for chronic wound drug delivery was assessed by loading them with an antibiotic (ciprofloxacin). In vitro bacterial culturing was performed using Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli). Results showed that at the same drug dosage, different release profiles achievable from cationic and anionic polyurethanes can yield different degrees of an antibacterial effect. Overall, our results suggest the potential application of cationic and anionic hydrophilic polyurethanes as flexible pH-responsive materials for the delivery of therapeutics to chronic wounds.
Collapse
Affiliation(s)
- Zhongyan Li
- Faculty of Engineering, School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, NSW 2006, Australia; (Z.L.); (M.C.); (T.S.); (H.K.N.V.); (A.M.-P.); (S.F.); (F.D.)
| | - Matthew Crago
- Faculty of Engineering, School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, NSW 2006, Australia; (Z.L.); (M.C.); (T.S.); (H.K.N.V.); (A.M.-P.); (S.F.); (F.D.)
| | - Timothy Schofield
- Faculty of Engineering, School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, NSW 2006, Australia; (Z.L.); (M.C.); (T.S.); (H.K.N.V.); (A.M.-P.); (S.F.); (F.D.)
| | - Haoxiang Zeng
- Key Centre for Polymers and Colloids, School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia; (H.Z.); (M.M.)
| | - Heema Kumari Nilesh Vyas
- Faculty of Engineering, School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, NSW 2006, Australia; (Z.L.); (M.C.); (T.S.); (H.K.N.V.); (A.M.-P.); (S.F.); (F.D.)
- Sydney Institute for Infectious Diseases, The University of Sydney, Sydney, NSW 2006, Australia
| | - Markus Müllner
- Key Centre for Polymers and Colloids, School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia; (H.Z.); (M.M.)
- Nano Institute (Sydney Nano), The University of Sydney, Sydney, NSW 2006, Australia
| | - Anne Mai-Prochnow
- Faculty of Engineering, School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, NSW 2006, Australia; (Z.L.); (M.C.); (T.S.); (H.K.N.V.); (A.M.-P.); (S.F.); (F.D.)
| | - Syamak Farajikhah
- Faculty of Engineering, School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, NSW 2006, Australia; (Z.L.); (M.C.); (T.S.); (H.K.N.V.); (A.M.-P.); (S.F.); (F.D.)
- Nano Institute (Sydney Nano), The University of Sydney, Sydney, NSW 2006, Australia
| | - Sina Naficy
- Faculty of Engineering, School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, NSW 2006, Australia; (Z.L.); (M.C.); (T.S.); (H.K.N.V.); (A.M.-P.); (S.F.); (F.D.)
- Nano Institute (Sydney Nano), The University of Sydney, Sydney, NSW 2006, Australia
| | - Fariba Dehghani
- Faculty of Engineering, School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, NSW 2006, Australia; (Z.L.); (M.C.); (T.S.); (H.K.N.V.); (A.M.-P.); (S.F.); (F.D.)
- Nano Institute (Sydney Nano), The University of Sydney, Sydney, NSW 2006, Australia
| | - Sepehr Talebian
- Faculty of Engineering, School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, NSW 2006, Australia; (Z.L.); (M.C.); (T.S.); (H.K.N.V.); (A.M.-P.); (S.F.); (F.D.)
- Nano Institute (Sydney Nano), The University of Sydney, Sydney, NSW 2006, Australia
| |
Collapse
|
3
|
Kassem A, Refai H, El-Nabarawi MA, Abdellatif MM. Formulation and Evaluation of Prednisolone Sodium Metazoate-Loaded Mucoadhesive Quatsomal Gel for Local Treatment of Recurrent Aphthous Ulcers: Optimization, In Vitro, Ex Vivo, and In Vivo Studies. Pharmaceutics 2023; 15:1947. [PMID: 37514134 PMCID: PMC10383094 DOI: 10.3390/pharmaceutics15071947] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2023] [Revised: 06/26/2023] [Accepted: 07/08/2023] [Indexed: 07/30/2023] Open
Abstract
This study aims to formulate a buccal mucoadhesive gel containing prednisolone sodium metazoate-loaded quatsomes for efficient localized therapy of recurrent aphthous ulcers. Quatsomes were prepared using a varied concentration of quaternary ammonium surfactants (QAS) and cholesterol (CHO). A 23 factorial design was conducted to address the impact of independent variables QAS type (X1), QAS to CHO molar ratio (X2), and sonication time (X3). The dependent variables were particle size (PS; Y1), polydispersity index (PDI; Y2), zeta potential (ZP; Y3), entrapment efficiency percent (EE%; Y4) and percent of drug released after 6 h (Q6%: Y5). Then, the selected quatsomes formula was incorporated into different gel bases to prepare an optimized mucoadhesive gel to be evaluated via in vivo study. The PS of the developed quatsomes ranged from 69.47 ± 0.41 to 113.28 ± 0.79 nm, the PDI from 0.207 ± 0.004 to 0.328 ± 0.004, ZP from 45.15 ± 0.19 to 68.1 ± 0.54 mV, EE% from 79.62 ± 1.44 to 98.60% ± 1.22 and Q6% from 58.39 ± 1.75 to 94.42% ± 2.15. The quatsomal mucoadhesive gel showed rapid recovery of ulcers, which was confirmed by the histological study and the evaluation of inflammatory biomarkers. These results assured the capability of the developed quatsomal mucoadhesive gel to be a promising formulation for treating buccal diseases.
Collapse
Affiliation(s)
- Ashraf Kassem
- Department of Pharmaceutics, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, Giza 12566, Egypt
| | - Hanan Refai
- Department of Pharmaceutics, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, Giza 12566, Egypt
| | - Mohamed A El-Nabarawi
- Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, El-Kasr El-Aini Street, Cairo 11562, Egypt
| | - Menna M Abdellatif
- Department of Industrial Pharmacy, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, Giza 12566, Egypt
| |
Collapse
|
4
|
Berlanga-Acosta J, Garcia-Ojalvo A, Guillen-Nieto G, Ayala-Avila M. Endogenous Biological Drivers in Diabetic Lower Limb Wounds Recurrence: Hypothetical Reflections. Int J Mol Sci 2023; 24:10170. [PMID: 37373317 DOI: 10.3390/ijms241210170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2023] [Revised: 05/22/2023] [Accepted: 05/25/2023] [Indexed: 06/29/2023] Open
Abstract
An impaired healing response underlies diabetic foot wound chronicity, frequently translating to amputation, disability, and mortality. Diabetics suffer from underappreciated episodes of post-epithelization ulcer recurrence. Recurrence epidemiological data are alarmingly high, so the ulcer is considered in "remission" and not healed from the time it remains epithelialized. Recurrence may result from the combined effects of behavioral and endogenous biological factors. Although the damaging role of behavioral, clinical predisposing factors is undebatable, it still remains elusive in the identification of endogenous biological culprits that may prime the residual scar tissue for recurrence. Furthermore, the event of ulcer recurrence still waits for the identification of a molecular predictor. We propose that ulcer recurrence is deeply impinged by chronic hyperglycemia and its downstream biological effectors, which originate epigenetic drivers that enforce abnormal pathologic phenotypes to dermal fibroblasts and keratinocytes as memory cells. Hyperglycemia-derived cytotoxic reactants accumulate and modify dermal proteins, reduce scar tissue mechanical tolerance, and disrupt fibroblast-secretory activity. Accordingly, the combination of epigenetic and local and systemic cytotoxic signalers induce the onset of "at-risk phenotypes" such as premature skin cell aging, dysmetabolism, inflammatory, pro-degradative, and oxidative programs that may ultimately converge to scar cell demise. Post-epithelialization recurrence rate data are missing in clinical studies of reputed ulcer healing therapies during follow-up periods. Intra-ulcer infiltration of epidermal growth factor exhibits the most consistent remission data with the lowest recurrences during 12-month follow-up. Recurrence data should be regarded as a valuable clinical endpoint during the investigational period for each emergent healing candidate.
Collapse
Affiliation(s)
- Jorge Berlanga-Acosta
- Tissue Repair, Wound Healing and Cytoprotection Research Group, Biomedical Research Direction, Center for Genetic Engineering and Biotechnology, Playa, Havana 10600, Cuba
| | - Ariana Garcia-Ojalvo
- Tissue Repair, Wound Healing and Cytoprotection Research Group, Biomedical Research Direction, Center for Genetic Engineering and Biotechnology, Playa, Havana 10600, Cuba
| | - Gerardo Guillen-Nieto
- Tissue Repair, Wound Healing and Cytoprotection Research Group, Biomedical Research Direction, Center for Genetic Engineering and Biotechnology, Playa, Havana 10600, Cuba
| | - Marta Ayala-Avila
- Tissue Repair, Wound Healing and Cytoprotection Research Group, Biomedical Research Direction, Center for Genetic Engineering and Biotechnology, Playa, Havana 10600, Cuba
| |
Collapse
|
5
|
Shakhakarmi K, Seo JE, Lamichhane S, Thapa C, Lee S. EGF, a veteran of wound healing: highlights on its mode of action, clinical applications with focus on wound treatment, and recent drug delivery strategies. Arch Pharm Res 2023; 46:299-322. [PMID: 36928481 DOI: 10.1007/s12272-023-01444-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2022] [Accepted: 03/09/2023] [Indexed: 03/18/2023]
Abstract
Epidermal growth factor (EGF) has been used in wound management and regenerative medicine since the late 1980s. It has been widely utilized for a long time and still is because of its excellent tolerability and efficacy. EGF has many applications in tissue engineering, cancer therapy, lung diseases, gastric ulcers, and wound healing. Nevertheless, its in vivo and during storage stability is a primary concern. This review focuses on the topical use of EGF, especially in chronic wound healing, the emerging use of biomaterials to deliver it, and future research possibilities. To successfully deliver EGF to wounds, a delivery system that is proteolytically resistant and stable over the long term is required. Biomaterials are an area of interest for the development of such systems. These systems may be used in non-healing wounds such as diabetic foot ulcers, pressure ulcers, and burns. In these pathologies, EGF can reduce the risk of amputation of the lower extremities, as it accelerates the wound healing process. Furthermore, appropriate delivery system would also stabilize and control the EGF release profile in a wound. Several in vitro and in vivo studies have already proven the efficacy of such systems in the above-mentioned types of wounds. Moreover, several formulations such as ointments and intralesional injections are already available on the market. However, these products are still problematic in terms of inadequate diffusion of EGF, low bioavailability storage conditions, and shelf-life. This review discusses the nano formulations comprising biomaterials infused with EGF which could be a promising delivery system for chronic wound healing in the future.
Collapse
Affiliation(s)
| | - Jo-Eun Seo
- College of Pharmacy, Keimyung University, Daegu, 704-701, Republic of Korea
| | | | - Chhitij Thapa
- College of Pharmacy, Keimyung University, Daegu, 704-701, Republic of Korea
| | - Sangkil Lee
- College of Pharmacy, Keimyung University, Daegu, 704-701, Republic of Korea.
| |
Collapse
|
6
|
Goyal N, Jerold F. Biocosmetics: technological advances and future outlook. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH INTERNATIONAL 2023; 30:25148-25169. [PMID: 34825334 PMCID: PMC8616574 DOI: 10.1007/s11356-021-17567-3] [Citation(s) in RCA: 10] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/01/2021] [Accepted: 11/12/2021] [Indexed: 04/16/2023]
Abstract
The paper provides an overview of biocosmetics, which has tremendous potential for growth and is attracting huge business opportunities. It emphasizes the immediate need to replace conventional fossil-based ingredients in cosmetics with natural, safe, and effective ingredients. It assembles recent technologies viable in the production/extraction of the bioactive ingredient, product development, and formulation processes, its rapid and smooth delivery to the target site, and fosters bio-based cosmetic packaging. It further explores industries that can be a trailblazer in supplying raw material for extraction of bio-based ingredients for cosmetics, creating biodegradable packaging, or weaving innovation in fashion clothing. Lastly, the paper discusses what it takes to become the first generation of a circular economy and supports the implementation of strict regulatory guidelines for any cosmetic sold globally.
Collapse
Affiliation(s)
- Nishu Goyal
- Department of Chemical Engineering, University of Petroleum and Energy Studies, Dehradun, 248007, India.
| | - Frankline Jerold
- Department of Chemical Engineering, University of Petroleum and Energy Studies, Dehradun, 248007, India
| |
Collapse
|
7
|
Martínez-Miguel M, Castellote-Borrell M, Köber M, Kyvik AR, Tomsen-Melero J, Vargas-Nadal G, Muñoz J, Pulido D, Cristóbal-Lecina E, Passemard S, Royo M, Mas-Torrent M, Veciana J, Giannotti MI, Guasch J, Ventosa N, Ratera I. Hierarchical Quatsome-RGD Nanoarchitectonic Surfaces for Enhanced Integrin-Mediated Cell Adhesion. ACS APPLIED MATERIALS & INTERFACES 2022; 14:48179-48193. [PMID: 36251059 PMCID: PMC9614722 DOI: 10.1021/acsami.2c10497] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 06/13/2022] [Accepted: 10/05/2022] [Indexed: 06/16/2023]
Abstract
The synthesis and study of the tripeptide Arg-Gly-Asp (RGD), the binding site of different extracellular matrix proteins, e.g., fibronectin and vitronectin, has allowed the production of a wide range of cell adhesive surfaces. Although the surface density and spacing of the RGD peptide at the nanoscale have already shown a significant influence on cell adhesion, the impact of its hierarchical nanostructure is still rather unexplored. Accordingly, a versatile colloidal system named quatsomes, based on fluid nanovesicles formed by the self-assembling of cholesterol and surfactant molecules, has been devised as a novel template to achieve hierarchical nanostructures of the RGD peptide. To this end, RGD was anchored on the vesicle's fluid membrane of quatsomes, and the RGD-functionalized nanovesicles were covalently anchored to planar gold surfaces, forming a state of quasi-suspension, through a long poly(ethylene glycol) (PEG) chain with a thiol termination. An underlying self-assembled monolayer (SAM) of a shorter PEG was introduced for vesicle stabilization and to avoid unspecific cell adhesion. In comparison with substrates featuring a homogeneous distribution of RGD peptides, the resulting hierarchical nanoarchitectonic dramatically enhanced cell adhesion, despite lower overall RGD molecules on the surface. The new versatile platform was thoroughly characterized using a multitechnique approach, proving its enhanced performance. These findings open new methods for the hierarchical immobilization of biomolecules on surfaces using quatsomes as a robust and novel tissue engineering strategy.
Collapse
Affiliation(s)
- Marc Martínez-Miguel
- Institut
de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain
- Biomedical
Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain
| | | | - Mariana Köber
- Institut
de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain
- Biomedical
Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain
| | - Adriana R. Kyvik
- Institut
de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain
- Biomedical
Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain
| | - Judit Tomsen-Melero
- Institut
de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain
- Biomedical
Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain
| | - Guillem Vargas-Nadal
- Institut
de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain
| | - Jose Muñoz
- Institut
de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain
| | - Daniel Pulido
- Biomedical
Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain
- Unidad
de Péptidos, UB, Unidad asociada
al CSIC por el IQAC, Barcelona 08028, Spain
| | - Edgar Cristóbal-Lecina
- Biomedical
Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain
- Unidad
de Péptidos, UB, Unidad asociada
al CSIC por el IQAC, Barcelona 08028, Spain
| | - Solène Passemard
- Institut
de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain
| | - Miriam Royo
- Biomedical
Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain
- Institut
de Química Avançada de Catalunya (IQAC−CSIC), Barcelona 08034, Spain
| | - Marta Mas-Torrent
- Institut
de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain
- Biomedical
Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain
| | - Jaume Veciana
- Institut
de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain
- Biomedical
Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain
| | - Marina I. Giannotti
- Biomedical
Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain
- Nanoprobes
and Nanoswitches group, Institute for Bioengineering of Catalonia
(IBEC), The Barcelona Institute of Science
and Technology (BIST), Barcelona 08028, Spain
- Departament
de Ciència dels Materials i Química Física, Universitat de Barcelona, Barcelona 08028, Spain
| | - Judith Guasch
- Institut
de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain
- Biomedical
Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain
- Dynamic Biomimetics
for Cancer Immunotherapy, Max Planck Partner
Group, ICMAB-CSIC, Campus UAB, Bellaterra 08193, Spain
| | - Nora Ventosa
- Institut
de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain
- Biomedical
Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain
| | - Imma Ratera
- Institut
de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain
- Biomedical
Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain
| |
Collapse
|
8
|
Morla-Folch J, Vargas-Nadal G, Fuentes E, Illa-Tuset S, Köber M, Sissa C, Pujals S, Painelli A, Veciana J, Faraudo J, Belfield KD, Albertazzi L, Ventosa N. Ultrabright Föster Resonance Energy Transfer Nanovesicles: The Role of Dye Diffusion. CHEMISTRY OF MATERIALS : A PUBLICATION OF THE AMERICAN CHEMICAL SOCIETY 2022; 34:8517-8527. [PMID: 36248229 PMCID: PMC9558306 DOI: 10.1021/acs.chemmater.2c00384] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
The development of contrast agents based on fluorescent nanoparticles with high brightness and stability is a key factor to improve the resolution and signal-to-noise ratio of current fluorescence imaging techniques. However, the design of bright fluorescent nanoparticles remains challenging due to fluorescence self-quenching at high concentrations. Developing bright nanoparticles showing FRET emission adds several advantages to the system, including an amplified Stokes shift, the possibility of ratiometric measurements, and of verifying the nanoparticle stability. Herein, we have developed Förster resonance energy transfer (FRET)-based nanovesicles at different dye loadings and investigated them through complementary experimental techniques, including conventional fluorescence spectroscopy and super-resolution microscopy supported by molecular dynamics calculations. We show that the optical properties can be modulated by dye loading at the nanoscopic level due to the dye's molecular diffusion in fluid-like membranes. This work shows the first proof of a FRET pair dye's dynamism in liquid-like membranes, resulting in optimized nanoprobes that are 120-fold brighter than QDot 605 and exhibit >80% FRET efficiency with vesicle-to-vesicle variations that are mostly below 10%.
Collapse
Affiliation(s)
- Judit Morla-Folch
- Institut
de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, Bellaterra, Catalonia 08193, Spain
- CIBER
de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)Instituto de Salud Carlos III. Bellaterra, 08193, Spain
| | - Guillem Vargas-Nadal
- Institut
de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, Bellaterra, Catalonia 08193, Spain
- CIBER
de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)Instituto de Salud Carlos III. Bellaterra, 08193, Spain
| | - Edgar Fuentes
- Nanoscopy
for Nanomedicine Group, Institute for Bioengineering
of Catalonia (IBEC) C\ Baldiri Reixac 15-21, Helix Building, Barcelona, 08028, Catalonia, Spain
| | - Sílvia Illa-Tuset
- Institut
de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, Bellaterra, Catalonia 08193, Spain
| | - Mariana Köber
- Institut
de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, Bellaterra, Catalonia 08193, Spain
- CIBER
de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)Instituto de Salud Carlos III. Bellaterra, 08193, Spain
| | - Cristina Sissa
- Dipartimento
di Scienze Chimiche, della Vita e della Sostenibilità Ambientale, Università di Parma, Parco Area delle Scienze 17/A, Parma, 43124, Italy
| | - Silvia Pujals
- Nanoscopy
for Nanomedicine Group, Institute for Bioengineering
of Catalonia (IBEC) C\ Baldiri Reixac 15-21, Helix Building, Barcelona, 08028, Catalonia, Spain
| | - Anna Painelli
- Dipartimento
di Scienze Chimiche, della Vita e della Sostenibilità Ambientale, Università di Parma, Parco Area delle Scienze 17/A, Parma, 43124, Italy
| | - Jaume Veciana
- Institut
de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, Bellaterra, Catalonia 08193, Spain
- CIBER
de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)Instituto de Salud Carlos III. Bellaterra, 08193, Spain
| | - Jordi Faraudo
- Institut
de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, Bellaterra, Catalonia 08193, Spain
| | - Kevin D. Belfield
- Department
of Chemistry and Environmental Science, College of Science and Liberal
Arts, New Jersey Institute of Technology
(NJIT) 323 Martin Luther King, Jr., Blvd., Newark, New Jersey 07102, United States
| | - Lorenzo Albertazzi
- Nanoscopy
for Nanomedicine Group, Institute for Bioengineering
of Catalonia (IBEC) C\ Baldiri Reixac 15-21, Helix Building, Barcelona, 08028, Catalonia, Spain
- Molecular
Biosensing for Medical Diagnostics Group, Biomedical Engineering, Technology Eindhoven University of Technology (TUE) Eindhoven, 5612 AZ, The Netherlands
| | - Nora Ventosa
- Institut
de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, Bellaterra, Catalonia 08193, Spain
- CIBER
de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)Instituto de Salud Carlos III. Bellaterra, 08193, Spain
| |
Collapse
|
9
|
Köber M, Illa-Tuset S, Ferrer-Tasies L, Moreno-Calvo E, Tatkiewicz WI, Grimaldi N, Piña D, Pérez Pérez A, Lloveras V, Vidal-Gancedo J, Bulone D, Ratera I, Skov Pedersenc J, Danino D, Veciana J, Faraudo J, Ventosa N. Stable nanovesicles formed by intrinsically planar bilayers. J Colloid Interface Sci 2022; 631:202-211. [DOI: 10.1016/j.jcis.2022.10.104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2022] [Revised: 10/16/2022] [Accepted: 10/20/2022] [Indexed: 11/06/2022]
|
10
|
Delivery systems for platelet derived growth factors in wound healing: A review of recent developments and global patent landscape. J Drug Deliv Sci Technol 2022. [DOI: 10.1016/j.jddst.2022.103270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
11
|
Mirhaj M, Labbaf S, Tavakoli M, Seifalian A. An Overview on the Recent Advances in the Treatment of Infected Wounds: Antibacterial Wound Dressings. Macromol Biosci 2022; 22:e2200014. [PMID: 35421269 DOI: 10.1002/mabi.202200014] [Citation(s) in RCA: 19] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2022] [Revised: 03/20/2022] [Indexed: 11/11/2022]
Abstract
A wound can be surgical, cuts from an operation or due to accident and trauma. The infected wound, as a result of bacteria growth within the damaged skin, interrupts the natural wound healing process and significantly impacts the quality of life. Wound dressing is an important segment of the skincare industry with its economic burden estimated at $ 20.4 billion (in 2021) in the global market. The results of recent clinical trials suggest that the use of modern dressings can be the easiest, most accessible, and most cost-effective way to treat chronic wounds and, hence, holds significant promise. With the sheer number of dressings in the market, the selection of correct dressing is confusing for clinicians and healthcare workers. The aim of this research was to review widely used types of antibacterial wound dressings, as well as emerging products, for their efficiency and mode of action. In this review, we focus on introducing antibiotics and antibacterial nanoparticles as two important and clinically widely used categories of antibacterial agents. The perspectives and challenges for paving the way for future research in this field are also discussed. This article is protected by copyright. All rights reserved.
Collapse
Affiliation(s)
- Marjan Mirhaj
- Department of Materials Engineering, Isfahan University of Technology, Isfahan, Iran
| | - Sheyda Labbaf
- Department of Materials Engineering, Isfahan University of Technology, Isfahan, Iran
| | - Mohamadreza Tavakoli
- Department of Materials Engineering, Isfahan University of Technology, Isfahan, Iran
| | - Amelia Seifalian
- Department of Surgery and Cancer, Imperial College London, London, United Kingdom
| |
Collapse
|
12
|
Ballell-Hosa L, González-Mira E, Santana H, Morla-Folch J, Moreno-Masip M, Martínez-Prieto Y, Revuelta A, Di Mauro PP, Veciana J, Sala S, Ferrer-Tasies L, Ventosa N. DELOS Nanovesicles-Based Hydrogels: An Advanced Formulation for Topical Use. Pharmaceutics 2022; 14:pharmaceutics14010199. [PMID: 35057095 PMCID: PMC8779640 DOI: 10.3390/pharmaceutics14010199] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2021] [Revised: 01/10/2022] [Accepted: 01/12/2022] [Indexed: 11/20/2022] Open
Abstract
Topical delivery has received great attention due to its localized drug delivery, its patient compliance, and its low risk for side effects. Recent developments have focused on studying new drug delivery systems as a strategy for addressing the challenges of current topical treatments. Here we describe the advances on an innovative drug delivery platform called DELOS nanovesicles for topical drug delivery. Previously, the production of DELOS nanovesicles demonstrated potentiality for the topical treatment of complex wounds, achieving well-tolerated liquid dispersions by this route. Here, research efforts have been focused on designing these nanocarriers with the best skin tolerability to be applied even to damaged skin, and on exploring the feasibility of adapting the colloidal dispersions to a more suitable dosage form for topical application. Accordingly, these drug delivery systems have been efficiently evolved to a hydrogel using MethocelTM K4M, presenting proper stability and rheological properties. Further, the integrity of these nanocarriers when being gellified has been confirmed by cryo-transmission electron microscopy and by Förster resonance energy transfer analysis with fluorescent-labeled DELOS nanovesicles, which is a crucial characterization not widely reported in the literature. Additionally, in vitro experiments have shown that recombinant human Epidermal Growth Factor (rhEGF) protein integrated into gellified DELOS nanovesicles exhibits an enhanced bioactivity compared to the liquid form. Therefore, these studies suggest that such a drug delivery system is maintained unaltered when hydrogellified, becoming the DELOS nanovesicles-based hydrogels, an advanced formulation for topical use.
Collapse
Affiliation(s)
- Lídia Ballell-Hosa
- Nanomol Technologies S.L., 08193 Cerdanyola del Vallès, Spain; (L.B.-H.); (S.S.)
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), 08193 Bellaterra, Spain; (E.G.-M.); (J.M.-F.); (M.M.-M.); (A.R.); (P.P.D.M.); (J.V.)
- Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain
| | - Elisabet González-Mira
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), 08193 Bellaterra, Spain; (E.G.-M.); (J.M.-F.); (M.M.-M.); (A.R.); (P.P.D.M.); (J.V.)
- Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain
| | - Hector Santana
- Center for Genetic Engineering and Biotechnology (CIGB), 31st Avenue between 158 and 190 Streets, Cubanacán, Playa, Havana 10600, Cuba; (H.S.); (Y.M.-P.)
| | - Judit Morla-Folch
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), 08193 Bellaterra, Spain; (E.G.-M.); (J.M.-F.); (M.M.-M.); (A.R.); (P.P.D.M.); (J.V.)
- Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain
| | - Marc Moreno-Masip
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), 08193 Bellaterra, Spain; (E.G.-M.); (J.M.-F.); (M.M.-M.); (A.R.); (P.P.D.M.); (J.V.)
| | - Yaima Martínez-Prieto
- Center for Genetic Engineering and Biotechnology (CIGB), 31st Avenue between 158 and 190 Streets, Cubanacán, Playa, Havana 10600, Cuba; (H.S.); (Y.M.-P.)
| | - Albert Revuelta
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), 08193 Bellaterra, Spain; (E.G.-M.); (J.M.-F.); (M.M.-M.); (A.R.); (P.P.D.M.); (J.V.)
| | - Primiano Pio Di Mauro
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), 08193 Bellaterra, Spain; (E.G.-M.); (J.M.-F.); (M.M.-M.); (A.R.); (P.P.D.M.); (J.V.)
- Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain
| | - Jaume Veciana
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), 08193 Bellaterra, Spain; (E.G.-M.); (J.M.-F.); (M.M.-M.); (A.R.); (P.P.D.M.); (J.V.)
- Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain
| | - Santi Sala
- Nanomol Technologies S.L., 08193 Cerdanyola del Vallès, Spain; (L.B.-H.); (S.S.)
| | - Lidia Ferrer-Tasies
- Nanomol Technologies S.L., 08193 Cerdanyola del Vallès, Spain; (L.B.-H.); (S.S.)
- Correspondence: (L.F.-T.); (N.V.)
| | - Nora Ventosa
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), 08193 Bellaterra, Spain; (E.G.-M.); (J.M.-F.); (M.M.-M.); (A.R.); (P.P.D.M.); (J.V.)
- Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain
- Correspondence: (L.F.-T.); (N.V.)
| |
Collapse
|